The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Adma Biologics Inc’s stock clocked out at $21.73, up 1.59% from its previous closing price of $21.39. In other words, the price has increased by $1.59 from its previous closing price. On the day, 3.11 million shares were traded.
Ratios:
To gain a deeper understanding of ADMA’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 50.26 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 46.94. For the most recent quarter (mrq), Quick Ratio is recorded 2.90 and its Current Ratio is at 5.97. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.23.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 15 ’25 when Grossman Adam S sold 21,000 shares for $21.46 per share. The transaction valued at 450,660 led to the insider holds 2,055,850 shares of the business.
Grossman Adam S sold 21,000 shares of ADMA for $397,320 on Mar 19 ’25. The President and CEO now owns 2,061,850 shares after completing the transaction at $18.92 per share. On Mar 19 ’25, another insider, Grossman Adam S, who serves as the Director and Officer of the company, bought 84,000 shares for $18.71 each.
Valuation Measures:
As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.85, and their Forward P/E ratio for the next fiscal year is 22.02. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.88. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.16 while its Price-to-Book (P/B) ratio in mrq is 14.73.
Stock Price History:
Over the past 52 weeks, ADMA has reached a high of $23.64, while it has fallen to a 52-week low of $6.23. The 50-Day Moving Average of the stock is 18.49%, while the 200-Day Moving Average is calculated to be 23.80%.
Shares Statistics:
A total of 236.62M shares are outstanding, with a floating share count of 230.23M. Insiders hold about 3.49% of the company’s shares, while institutions hold 85.91% stake in the company.
